483
JICE Pharmaceuticals CompanyFDA 483 - JICE Pharmaceuticals Company - May 23, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
JICE Pharmaceuticals Company in Belding, MI, received a Form FDA 483 with four repeat observations during an inspection from May 21-23, 2025. The inspection revealed significant deficiencies in drug product testing, batch record management, component supplier qualification, and the stability program. These issues indicate a lack of adherence to good manufacturing practices, potentially impacting drug product quality.
- Office
- Detroit District Office
- Person
Open in Dashboard
ID · e6761f34-52be-4a5b-91be-9cd151cb2ee5